日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC)

针对共同的非突变抗原和共同的突变BRAF新抗原的黑色素瘤疫苗的I/II期临床试验，采用激动性CD40抗体（CDX-1140）和TLR3激动剂（poly-ICLC）

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013613
Ninmer, Emily K; Petroni, Gina R; Gastman, Brian R; Gaughan, Elizabeth M; Isaacs, James M; Haden, Kathleen; Kaur, Varinder; Wages, Nolan A; Chianese-Bullock, Kimberly A; Smith, Kelly T; Wright, Paul; Bryant, Jennifer; Dunlap-Brown, Marya; Engel, Jack A; Bekiranov, Stefan; Mauldin, Ileana S; Truong, Thach-Giao; Bullock, Timothy N J; Slingluff, Craig L Jr
黑色素瘤
T细胞
BRAF
CD40
CLC
CD4
发表日期：2026
文献求助 收藏

Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab)

随机 I/II 期临床试验，评估黑色素瘤辅助肽疫苗联合或不联合全身性激动性抗 CD27 抗体（Varlilumab）的疗效

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-25-0744
Ninmer, Emily K; Petroni, Gina R; Gaughan, Elizabeth; Poklepovic, Andrew S; Kaur, Varinder; Haden, Kathleen; Chianese-Bullock, Kimberly A; Smith, Kelly T; Wright, Paul; Bryant, Jennifer L; Brighton, David; Engel, Jack A; Bullock, Timothy N J; Slingluff, Craig L Jr
CD2
CD27
黑色素瘤
发表日期：2026
文献求助 收藏

Addendum: Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial

附录：多肽疫苗在黑色素瘤辅助治疗中的应用：一项随机 II 期试验的长期生存结果和事后分析

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-63690-x
Ninmer, Emily K; Zhu, Hong; Chianese-Bullock, Kimberly A; von Mehren, Margaret; Haas, Naomi B; Ross, Merrick I; Dengel, Lynn T; Slingluff, Craig L Jr
黑色素瘤
发表日期：2025
文献求助 收藏

Twenty-year survival outcomes after multipeptide vaccination for resected high-risk melanoma: A post-hoc analysis of a randomized clinical trial

多肽疫苗接种治疗切除的高危黑色素瘤患者的20年生存结果：一项随机临床试验的事后分析

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.70006
Ninmer, Emily K; Zhu, Hong; Chianese-Bullock, Kimberly A; Slingluff, Craig L Jr
黑色素瘤
发表日期：2025
文献求助 收藏

The Landmark Series: Cancer Vaccines for Solid Tumors

里程碑系列：实体瘤癌症疫苗

期刊:Annals of Surgical Oncology
影响因子:3.5
doi:10.1245/s10434-024-16712-9
Ninmer, Emily K; Xu, Feifan; Slingluff, Craig L Jr
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial

多肽疫苗在黑色素瘤辅助治疗中的应用：一项随机II期试验的长期生存结果和事后分析

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-46877-6
Ninmer, Emily K; Zhu, Hong; Chianese-Bullock, Kimberly A; von Mehren, Margaret; Haas, Naomi B; Ross, Merrick I; Dengel, Lynn T; Slingluff, Craig L Jr
黑色素瘤
发表日期：2024
文献求助 收藏